Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

ARR

ARMOUR Residential REIT's $22.2 Billion Portfolio

ARMOUR Residential REIT ended May with a $22.2 billion portfolio, up from the prior period’s level implied by its larger agency concentration and swap book, while its common stock traded at $17.15 and its market capitalization stood at $2.06 billion.

The company’s portfolio remained heavily concentrated in agency mortgage-backed securities, which made up 93.8% of total holdings, or $20.8 billion. Within that, 30-year fixed-rate pools accounted for 87.9% of the portfolio, or $19.5 billion. The largest coupon buckets were 30-year 5.5s at 25.6% of the portfolio, 30-year 5.0s at 18.6%, and 30-year 6.0s at 16.2%. Agency CMBS represented 5.9%, or $1.3 billion, and U.S. Treasury longs totaled 4.4%, or $982 million.

ARMOUR reported leverage of 7.9 times debt-to-equity and implied leverage of 8.0 times. Liquidity was $1.16 billion, equal to 46% of total capital.

The June common dividend was set at $0.24 per share, with a current dividend yield of 16.8%.

On the financing side, total repo borrowing was $19.9 billion. Buckler Securities provided $9.29 billion of that, representing 46.8% of repo positions, while all other counterparties supplied $10.57 billion, or 53.2%. The weighted average original repo term was 583 days with a 37-day weighted average remaining term.

ARMOUR’s swap book totaled $15.34 billion notional. The largest maturity bucket was 25 to 36 months at $3.59 billion, followed by 13 to 24 months at $2.50 billion and 49 to 60 months at $2.15 billion. The weighted average remaining term across swaps was 53 months, and the weighted average rate was 2.74%.

ARMOUR also held a 10.8% equity interest in Buckler Securities. Following these announcements, the company's shares moved -0.17%, and are now trading at a price of $17.10. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS